Duran-Frigola Miquel, Aloy Patrick
Joint IRB-BSC Program in Computational Biology, Institute for Research in Biomedicine, c/ Baldiri Reixac 10-12, 08028 Barcelona, Spain.
Chem Biol. 2013 Apr 18;20(4):594-603. doi: 10.1016/j.chembiol.2013.03.017.
Side effects (SEs) are the unintended consequence of therapeutic treatments, but they can also be seen as valuable readouts of drug effects, resulting from the perturbation of biological systems by chemical compounds. Unfortunately, biology and chemistry are often considered separately, leading to incomplete models unable to provide a unified view of SEs. Here, we investigate the molecular bases of over 1,600 SEs by navigating both chemical and biological spaces. We identified characteristic molecular traits for 1,162 SEs, 38% of which can be explained using solely biological arguments, and only 6% are exclusively associated with the chemistry of the compounds, implying that the drug action is somewhat unspecific. Overall, we provide mechanistic insights for most SEs and emphasize the need to blend biology and chemistry to surpass intricate phenomena not captured in the molecular biology view.
副作用是治疗性治疗产生的意外后果,但它们也可被视为药物效应的有价值的读出结果,这是由化合物对生物系统的扰动所导致的。不幸的是,生物学和化学常常被分开考虑,导致模型不完整,无法提供对副作用的统一观点。在这里,我们通过在化学和生物空间中导航来研究1600多种副作用的分子基础。我们确定了1162种副作用的特征分子特征,其中38%仅用生物学观点就能解释,只有6%完全与化合物的化学性质相关,这意味着药物作用在某种程度上是非特异性的。总体而言,我们为大多数副作用提供了机制性见解,并强调需要将生物学和化学结合起来,以超越分子生物学观点中未涵盖的复杂现象。